• 1 view
Συντονιστές
Wischhusen J.
Xagara A.
Add to agenda

Presentations

PROGNOSTIC SIGNIFICANCE OF SHP2 EXPRESSION IN NON-SMALL LUNG CANCER PATIENTS
Mark as live Clear stage
CONCOMITANT CAUSES OF ANAEMIA IN A PATIENT WITH LUNG ADENOCARCINOMA UNDER anti-PD-1 IMMUNOTHERAPY
Mark as live Clear stage
DISTINCT PROFILE OF PROLIFERATING CD8+/TCF1+ T CELLS AMONG DIFFERENT BREAST CANCER MOLECULAR SUBTYPES
Mark as live Clear stage
Fc ENGINEERED MONOCLONAL ANTIBODIES FOR TRIPLE NEGATIVE BREAST CANCER THERAPY
Mark as live Clear stage
EFFECT OF THE MEK INHIBITOR COBIMETINIB ON BRAF V600E MUTATED THYROID CARCINOMA
Mark as live Clear stage

Speaker